Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /*.php$ Disallow: /*.php* Disallow: /etc/ Disallow: /docs/ Disallow: /role/ Disallow: */_jcr_content/* Sitemap: https://drugdevelopment.labcorp.com/sitemap.xml Sitemap: https://www.globalsiteseo.com/covance.GSM/covance.gsm.index.en_super.xml Sitemap: https://www.globalsiteseo.com/covance.GSM/covance.gsm.index.de_super.xml Sitemap: https://www.globalsiteseo.com/covance.GSM/covance.gsm.index.es_super.xml Sitemap: https://www.globalsiteseo.com/covance.GSM/covance.gsm.index.fr_super.xml Sitemap: https://www.globalsiteseo.com/covance.GSM/covance.gsm.index.ja_super.xml Sitemap: |
Title | Contract Research Organization (CRO) and Clinical Trials | Labcorp Drug |
Description | Labcorp Drug Development (formerly Covance) is a global contract research organization (CRO) that provides drug development services with the goal of advancing health. We have supported the development of the top 50 pharmaceutical drugs on the |
Keywords | N/A |
WebSite | covance.com |
Host IP | 104.18.0.25 |
Location | Malaysia |
Site | Rank |
US$11,481,303
Last updated: 2023-04-26 19:05:30
covance.com has Semrush global rank of 921,873. covance.com has an estimated worth of US$ 11,481,303, based on its estimated Ads revenue. covance.com receives approximately 1,324,766 unique visitors each day. Its web server is located in Malaysia, with IP address 104.18.0.25. According to SiteAdvisor, covance.com is safe to visit. |
Purchase/Sale Value | US$11,481,303 |
Daily Ads Revenue | US$10,599 |
Monthly Ads Revenue | US$317,944 |
Yearly Ads Revenue | US$3,815,326 |
Daily Unique Visitors | 88,318 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
covance.com. | A | 86399 | IP: 104.18.0.25 |
covance.com. | A | 86399 | IP: 104.18.1.25 |
covance.com. | NS | 86400 | NS Record: dns3.labcorp.com. |
covance.com. | NS | 86400 | NS Record: dns4.labcorp.com. |
covance.com. | MX | 10800 | MX Record: 20 nadcsmtp04.covance.com. |
covance.com. | MX | 10800 | MX Record: 10 nadcsmtp02.covance.com. |
covance.com. | MX | 10800 | MX Record: 10 nadcsmtp01.covance.com. |
covance.com. | MX | 10800 | MX Record: 20 nadcsmtp03.covance.com. |
covance.com. | TXT | 300 | TXT Record: lynvtt14tydy25klvsdmsp98mxhdw7nl |
covance.com. | TXT | 300 | TXT Record: ns82vw6psxd0nbxl90qt3gjvnlxtxtt9 |
covance.com. | TXT | 300 | TXT Record: atlassian-domain-verification=bv78I3Ryv09rlhGsWIyRgFNuy3pnZwuAbOADGI/cbfuDFklnHFg6VIpDLEu4DIwU |
covance.com. | TXT | 300 | TXT Record: adobe-idp-site-verification=fa373cc635a85d4230f783cb97266eefb65c34e4ed1574253364969e82f96e52 |
covance.com. | TXT | 300 | TXT Record: v=msv1 t=023FF51D-2E4A-4623-8111-0BFBC5380D7D |
covance.com. | TXT | 300 | TXT Record: MS=ms20057178 |
covance.com. | TXT | 300 | TXT Record: onetrust-domain-verification=5d13a0ec1b07490a8b1ccabf305b7eb5 |
covance.com. | TXT | 300 | TXT Record: v=spf1 include:spf-00266502.pphosted.com ip4:208.66.166.156 ip4:208.66.166.157 ip4:208.66.166.215 ip4:208.66.166.216 ip4:208.66.166.171 ip4:208.66.166.19 ip4:208.66.166.20 ip4:68.232.128.0/19 ip4:137.116.54.124 ip4:104.208.237.83 ip4:208.66.166.13 -all |
covance.com. | TXT | 300 | TXT Record: 11Og3daspClRtsIc/0fn43V53LRoQpd/eglacVLUjTJfOA/DxxWPimqqMFzGR/ZErCF4ldNTkqPJFHMDSy8sgA== |
covance.com. | TXT | 300 | TXT Record: ciscocidomainverification=741467ec15c9b40c20b07841aad6c6f4160cffc80dabdbed488bad00e9be7128 |
covance.com. | TXT | 300 | TXT Record: Dynatrace-site-verification=7f45512d-ea82-4e3b-b267-70d92b10dcb4__upc7fks47dfrvafqp8d9dem6io |
covance.com. | TXT | 300 | TXT Record: docusign=0fd685b0-225f-41e0-9bdf-4150b4742713 |
covance.com. | TXT | 300 | TXT Record: docusign=1bda1931-942a-4414-bfc8-a2cdcf2b272d |
covance.com. | TXT | 300 | TXT Record: smartsheet-site-validation=X2WNHWdE20rotHpW30tS6ZzJpCvTH7tr |
covance.com. | TXT | 300 | TXT Record: xz3yz7kxt5gz8h44pw43ntgmgp638ldv |
covance.com. | TXT | 300 | TXT Record: ecostruxure-it-verification=088dcb9c-9cf4-4060-899a-f54149baa95a |
covance.com. | TXT | 300 | TXT Record: flexera-domain-verification-owwxyldqrpsjsydw |
covance.com. | TXT | 300 | TXT Record: 3j0kggb5lq28j1vqgc3w8mslhzxg3zs1 |
covance.com. | TXT | 300 | TXT Record: rn8rrcjfrpybb2l4g5npw8n8rp0k7w0x |
covance.com. | TXT | 300 | TXT Record: z8x4f0p4m09ms6dplkfsb0ffvb7s4tkd |
covance.com. | TXT | 300 | TXT Record: kffmklsdhg651flnfv72f6stsxy0p0tw |
covance.com. | TXT | 300 | TXT Record: 4kzzfp682jvtl4yvdzt2qm5g3hjszszz |
covance.com. | TXT | 300 | TXT Record: l126n9z05yb1my89t5fxnk9q79kcrj2n |
covance.com. | TXT | 300 | TXT Record: 5lnvds48vx02fnk718sgcxtdjwy6s7kv |
covance.com. | TXT | 300 | TXT Record: mb3pf8l7kq4n0f4pv4vsw859lpvczs6m |
Kit Orders Find a Trial Labcorp.com Medtech Crop Chemical Careers Choose Language Solutions Solutions Back Drug Development Drug Development Back By Phase By Therapeutic By Therapeutic Back Cardiovascular Dermatology Diabetes and Endocrinology Inflammation NASH Neuroscience & CNS Rare & Orphan Ophthalmology Pediatrics Infectious Disease & Vaccines Nephrology Lung & Respiratory By Region By Region Back Asia Pacific By Molecule or Product By Molecule or Product Back Biologic Drug Development & Testing Small Molecule Biosimilars Development Solutions Oncology Oncology Back Preclinical Preclinical Back Model & tech spotlights Tumor models ACT & CAR T In vitro Posters Fast Track Discovery Clinical trials Clinical trials Back Consulting team Patient Recruitment Immunotherapy Immunotherapy Back Preclinical Clinical Education Education Back Top 5 Models for Immuno-oncology Studies Top 5 Design Considerations for Preclinical Immuno-oncology Events Contact Services Services Back Analysis |
HTTP/1.1 301 Moved Permanently Date: Wed, 20 Oct 2021 06:53:09 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Wed, 20 Oct 2021 07:53:09 GMT Location: https://drugdevelopment.labcorp.com/ Server: cloudflare CF-RAY: 6a1053d82abd4951-STL HTTP/2 200 date: Wed, 20 Oct 2021 06:53:10 GMT content-type: text/html;charset=utf-8 set-cookie: AWSALB=mj6/cBc/srtk2htJTac/yG53Mqahnp07IlfNe17OVeoZlugkNRd5epbqxYoaxnkcXUrn7jkirv+KXkrH9itxB78MxcUEOc/A9FyTd4o7jIG5vOo1y4PuKrl8oMtR; Expires=Wed, 27 Oct 2021 06:53:10 GMT; Path=/ set-cookie: AWSALBCORS=mj6/cBc/srtk2htJTac/yG53Mqahnp07IlfNe17OVeoZlugkNRd5epbqxYoaxnkcXUrn7jkirv+KXkrH9itxB78MxcUEOc/A9FyTd4o7jIG5vOo1y4PuKrl8oMtR; Expires=Wed, 27 Oct 2021 06:53:10 GMT; Path=/; SameSite=None; Secure x-content-type-options: nosniff last-modified: Tue, 19 Oct 2021 20:11:20 GMT cache-control: max-age=120960 expires: Thu, 21 Oct 2021 16:29:10 GMT vary: Accept-Encoding,User-Agent dispatcher: ${DISP_NUM} x-dispatcher: ${DISP_NUM} x-vhost: covance x-frame-options: SAMEORIGIN cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a1053d93be62c74-ORD |
Domain Name: COVANCE.COM Registry Domain ID: 2196256_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-03-10T06:14:36Z Creation Date: 1997-03-13T05:00:00Z Registry Expiry Date: 2022-03-14T04:00:00Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: DNS3.LABCORP.COM Name Server: DNS4.LABCORP.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-08T14:58:24Z <<< |